People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Healthtech, Other Health Care, Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ShockWave Medical, Inc. | — | Healthtech | Series C | $144.8M | $255.8M | 2018 |
| HeartWare International, Inc. | — | Other Health Care | Series C | $55.2M | $5.0M | 2009 |
| EyePoint Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $25.6M | $437.8M | 2018 |
| NuPulseCV, Inc. | — | Biotechnology | Series A | $14.7M | $75.9M | 2011 |
Douglas Godshall at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Godshall on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 1 | 19 |
| Scott Jones | 1 | 11 |
| Frederic Moll | 1 | 10 |
| Robert Thomas | 1 | 8 |
| Frederic H. Moll | 1 | 8 |
| Timothy Barberich | 1 | 6 |
| Jay Watkins | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| ANTOINE PAPIERNIK | 1 | 6 |
| James Barry | 1 | 5 |
| David McIntyre | 1 | 5 |
| Daniel Hawkins | 1 | 4 |
| RICHARD SHERMAN | 1 | 3 |
| Kristine Peterson | 1 | 3 |
| David Mazzo | 1 | 3 |
| Doug Godshall | 1 | 3 |
| Greg Scott | 1 | 3 |
| Michael Rogers | 1 | 3 |
| BRIAN NOVACK | 1 | 2 |
| Laura Francis | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.